Matches in Wikidata for { <http://www.wikidata.org/entity/Q93150773> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q93150773 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93150773 description "scientific article published on 22 April 2020" @default.
- Q93150773 description "wetenschappelijk artikel" @default.
- Q93150773 description "наукова стаття, опублікована 22 квітня 2020" @default.
- Q93150773 name "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 name "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 type Item @default.
- Q93150773 label "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 label "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 prefLabel "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 prefLabel "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 P1433 Q93150773-08FA4260-074B-4B9B-A2A7-9A9F4781BFA1 @default.
- Q93150773 P1476 Q93150773-5840966D-BC44-4A3B-A220-2AF5E0D259C1 @default.
- Q93150773 P2093 Q93150773-135AE3A7-20E6-417D-845E-2EF8F46758EE @default.
- Q93150773 P2093 Q93150773-9AA5622C-CA46-45C6-85F4-245CE536430C @default.
- Q93150773 P2093 Q93150773-D1B3CDFE-945C-42E1-AC3B-AD4B80DF77D1 @default.
- Q93150773 P2093 Q93150773-DC8ED280-A3F6-4B13-9E18-3AD4B541F633 @default.
- Q93150773 P2093 Q93150773-E80170F2-751C-4447-9270-A5EF27693883 @default.
- Q93150773 P2093 Q93150773-F80830C3-F621-4CFC-94F6-76008EDD9DDF @default.
- Q93150773 P31 Q93150773-D4221A37-4377-4665-B0A3-37D62E4BE0B5 @default.
- Q93150773 P356 Q93150773-C8F86639-216C-473B-97A6-9A2D27B5ACD1 @default.
- Q93150773 P577 Q93150773-7C6478CD-FA25-404F-BD95-AC5B6C067877 @default.
- Q93150773 P698 Q93150773-BD815F28-F83D-439C-AE5D-6416567C0B4B @default.
- Q93150773 P921 Q93150773-0E3BE01F-662B-40E1-BBC0-3BF4091AB025 @default.
- Q93150773 P356 BJD.19151 @default.
- Q93150773 P698 32320476 @default.
- Q93150773 P1433 Q4970191 @default.
- Q93150773 P1476 "Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic center in France" @default.
- Q93150773 P2093 "A Clapé" @default.
- Q93150773 P2093 "C Muller" @default.
- Q93150773 P2093 "C Vanhaecke" @default.
- Q93150773 P2093 "J Plée" @default.
- Q93150773 P2093 "M Viguier" @default.
- Q93150773 P2093 "P Bernard" @default.
- Q93150773 P31 Q13442814 @default.
- Q93150773 P356 "10.1111/BJD.19151" @default.
- Q93150773 P577 "2020-04-22T00:00:00Z" @default.
- Q93150773 P698 "32320476" @default.
- Q93150773 P921 Q1004647 @default.